Sharechat Logo

NZ residential building consents fall 1.7 percent in February, led by apartments

Monday 31st March 2014

Text too small?

New Zealand building consents for residential housing fell 1.7 percent in February, the second straight monthly decline, as the number of apartments extended their decline from record levels at the end of 2013.

New dwelling consents, including apartments, fell to a seasonally adjusted 1,915 in February from 1,949 in January, according to Statistics New Zealand. Excluding apartments and units, which are typically volatile from month to month, seasonally adjusted consents rose 3 percent to 1,805.

Annual residential issuance rose 14.7 percent from a year earlier, or up 21.6 percent excluding apartments. There were an unadjusted 21,842 consents issued in February. Of that, 19,414 were for new houses and 2,428 for apartments.

New dwelling consents rose to 464 in Auckland in February from 433 the previous month, while in Canterbury they climbed to 530 from 520.

Today's figures show the value of non-residential building consents rose 13 percent to $4.4 billion in the year ended in February while the value for residential buildings gained 27 percent to $8.17 billion. The value of all building consents rose 22 percent to $12.5 billion.

 

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors